ID24530A - Turunan-turunan makrolidan yang tersubstitusi c-4 - Google Patents

Turunan-turunan makrolidan yang tersubstitusi c-4

Info

Publication number
ID24530A
ID24530A IDW991565A ID991565A ID24530A ID 24530 A ID24530 A ID 24530A ID W991565 A IDW991565 A ID W991565A ID 991565 A ID991565 A ID 991565A ID 24530 A ID24530 A ID 24530A
Authority
ID
Indonesia
Prior art keywords
macrolidant
deposits
substituted
macrolidant deposits
Prior art date
Application number
IDW991565A
Other languages
English (en)
Indonesian (id)
Inventor
Brian Scott
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of ID24530A publication Critical patent/ID24530A/id

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
IDW991565A 1997-06-11 1998-05-25 Turunan-turunan makrolidan yang tersubstitusi c-4 ID24530A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4998097P 1997-06-11 1997-06-11

Publications (1)

Publication Number Publication Date
ID24530A true ID24530A (id) 2000-07-20

Family

ID=21962765

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW991565A ID24530A (id) 1997-06-11 1998-05-25 Turunan-turunan makrolidan yang tersubstitusi c-4

Country Status (39)

Country Link
EP (1) EP0988309B1 (de)
JP (1) JP3262806B2 (de)
KR (1) KR100369959B1 (de)
CN (1) CN1145636C (de)
AP (1) AP1189A (de)
AR (1) AR013085A1 (de)
AT (1) ATE310742T1 (de)
AU (1) AU745006C (de)
BG (1) BG64357B1 (de)
BR (1) BR9810097A (de)
CA (1) CA2293397C (de)
CO (1) CO4950584A1 (de)
DE (1) DE69832486T2 (de)
DZ (1) DZ2515A1 (de)
EA (1) EA002440B1 (de)
ES (1) ES2251081T3 (de)
GT (1) GT199800075A (de)
HN (1) HN1998000074A (de)
HR (1) HRP980315A2 (de)
HU (1) HUP0004076A3 (de)
ID (1) ID24530A (de)
IL (1) IL132808A (de)
IS (1) IS1979B (de)
MA (1) MA24563A1 (de)
MY (1) MY133027A (de)
NO (1) NO315560B1 (de)
NZ (1) NZ500652A (de)
OA (1) OA11226A (de)
PA (1) PA8452001A1 (de)
PE (1) PE79999A1 (de)
PL (1) PL337497A1 (de)
SK (1) SK168299A3 (de)
TN (1) TNSN98084A1 (de)
TW (2) TWI224106B (de)
UA (1) UA70298A (de)
UY (1) UY25041A1 (de)
WO (1) WO1998056801A1 (de)
YU (1) YU62999A (de)
ZA (1) ZA985016B (de)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU731842B2 (en) * 1997-09-10 2001-04-05 Merck & Co., Inc. 9a-azalides as veterinary antimicrobial agents
EP1779853A3 (de) * 1997-09-10 2010-01-27 Merial Ltd. 9a-Azalide als antimikrobielle Wirkstoffe für die Veterinärmedizin
US6339063B1 (en) 1997-09-10 2002-01-15 Merck & Co., Inc. 9a-azalides as veterinary antimicrobial agents
AP9801420A0 (en) * 1998-01-02 1998-12-31 Pfizer Prod Inc Novel macrolides.
US6043227A (en) * 1998-08-19 2000-03-28 Pfizer Inc. C11 carbamates of macrolide antibacterials
EP1437360A3 (de) * 1998-08-19 2005-04-06 Pfizer Products Inc. C11-Carbamate von antibakteriellen Makroliden
US6100240A (en) * 1998-10-09 2000-08-08 Pfizer Inc Macrolide derivatives
ID28286A (id) 1998-11-03 2001-05-10 Pfizer Prod Inc Antibiotik-antibiotik makrolida baru
CA2292359C (en) * 1999-01-28 2004-09-28 Pfizer Products Inc. Novel azalides and methods of making same
US6764996B1 (en) 1999-08-24 2004-07-20 Abbott Laboratories 9a-azalides with antibacterial activity
CA2380455C (en) * 1999-08-24 2009-06-02 Abbott Laboratories 9a-azalides with antibacterial activity
ATE243703T1 (de) 2000-01-27 2003-07-15 Pfizer Prod Inc Antibiotische azalid-zusammensetzungen
CN100413879C (zh) * 2001-04-27 2008-08-27 辉瑞产品公司 4″-取代-9-脱氧-9a-氮杂-9a-高红霉素A衍生物的制备方法
JP2003040782A (ja) * 2001-05-31 2003-02-13 Pfizer Prod Inc アザリド抗生物質組成物
EP1551865B1 (de) 2002-07-08 2009-04-22 GlaxoSmithKline istrazivacki centar Zagreb d.o.o. Hybridmoleküle von makroliden mit steroidalen/nicht-steroidalen antientzündlich aktiven molekülen
AU2003255849A1 (en) * 2002-07-08 2004-01-23 Glaxosmithkline Istrazivacki Centar Zagreb D.O.O. Novel nonsteroidal anti-inflammatory substances, compositions and methods for their use
WO2004005310A2 (en) 2002-07-08 2004-01-15 Pliva-Istrazivacki Institut D.O.O. New compounds, compositions and methods for treatment of inflammatory diseases and conditions
AR043050A1 (es) 2002-09-26 2005-07-13 Rib X Pharmaceuticals Inc Compuestos heterociclicos bifuncionales y metodos para preparar y usar los mismos
US7601695B2 (en) * 2003-03-10 2009-10-13 Optimer Pharmaceuticals, Inc. Antibacterial agents
WO2005030227A1 (en) 2003-09-23 2005-04-07 Enanta Pharmaceuticals, Inc. 9a, 11-3C-BICYCLIC 9a-AZALIDE DERIVATIVES
EP1723159B1 (de) 2004-02-27 2019-06-12 Melinta Therapeutics, Inc. Makrozyklische verbindungen, deren herstellung und verwendung
WO2009019868A1 (ja) 2007-08-06 2009-02-12 Taisho Pharmaceutical Co., Ltd. 10a、12位架橋型10a-アザライド化合物
EP2214484A4 (de) 2007-10-25 2013-01-02 Cempra Pharmaceuticals Inc Verfahren zur herstellung von antibakteriellen makrolid-wirkstoffen
US8299035B2 (en) 2008-05-15 2012-10-30 Taisho Pharmaceutucal Co., Ltd. 10a-azalide compound having 4-membered ring structure
CN102245195B (zh) 2008-10-24 2016-01-13 森普拉制药公司 使用含三唑的大环内酯的生物防御
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
CN103080121B (zh) * 2010-09-20 2015-11-25 瑞士诺华动物保健有限公司 用于制备在二脱氧甲基己糖环的C-4”处被环氧基团修饰的9-脱氧-9a-氮杂-9a-高红霉素A的新方法
AR085286A1 (es) * 2011-02-21 2013-09-18 Taisho Pharmaceutical Co Ltd Derivado de macrolido sustituido en la posicion c-4
CA2868262A1 (en) 2012-03-27 2013-10-03 Cempra Pharmaceuticals, Inc. Parenteral formulations for administering macrolide antibiotics
JP5857008B2 (ja) * 2012-08-20 2016-02-10 大正製薬株式会社 C−4”位置換マクロライド誘導体を含有する医薬
KR102363621B1 (ko) * 2013-04-04 2022-02-25 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 매크롤라이드 그리고 그의 제조방법 및 용도
CN103965273B (zh) * 2013-08-23 2016-05-25 普莱柯生物工程股份有限公司 一种大环内酯类化合物
CN105669798B (zh) * 2013-08-23 2019-07-26 普莱柯生物工程股份有限公司 一种大环内酯类化合物
AR102810A1 (es) 2014-08-18 2017-03-29 Taisho Pharmaceutical Co Ltd Derivado de macrólido sustituido en la posición c-4
CA2963815A1 (en) 2014-10-08 2016-04-14 President And Fellows Of Harvard College 14-membered ketolides and methods of their preparation and use
WO2016154591A1 (en) 2015-03-25 2016-09-29 President And Fellows Of Harvard College Macrolides with modified desosamine sugars and uses thereof
CN108003207B (zh) 2017-12-19 2019-05-10 海门慧聚药业有限公司 制备泰拉霉素的方法
EP4118091B1 (de) * 2020-03-12 2025-06-18 Zoetis Services LLC Immunomodulierende harnstoff-azalide

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4150220A (en) * 1977-02-04 1979-04-17 Pfizer Inc. Semi-synthetic 4"-erythromycin A derivatives
SE445223B (sv) * 1977-02-04 1986-06-09 Pfizer Sett att framstella 4"-amino-erytomylin-a-derivat
YU43006B (en) * 1981-03-06 1989-02-28 Pliva Pharm & Chem Works Process for preparing n-methyl-11-aza-10-deoxo-10-dihydro erythromycin and derivatives thereof
US4474768A (en) * 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
DE3475073D1 (en) * 1983-09-06 1988-12-15 Pfizer Azahomoerythromycin b derivatives and intermediates thereof
US4512982A (en) * 1984-04-13 1985-04-23 Pfizer Inc. 9α-Aza-9α-homoerythromycin compounds, pharmaceutical composition and therapeutic method
CA2064634C (en) * 1991-04-04 1998-08-04 James V. Heck 9-deoxo-8a-aza-8a-homoerythromycin a derivatives modified at the 4"- and8a-positions
US5441939A (en) * 1994-03-04 1995-08-15 Pfizer Inc. 3"-desmethoxy derivatives of erythromycin and azithromycin
US5412982A (en) * 1994-03-10 1995-05-09 Potts; James K. Windsock support

Also Published As

Publication number Publication date
AR013085A1 (es) 2000-12-13
WO1998056801A1 (en) 1998-12-17
EP0988309A1 (de) 2000-03-29
EA002440B1 (ru) 2002-04-25
HK1025974A1 (en) 2000-12-01
KR100369959B1 (ko) 2003-02-12
IS5250A (is) 1999-11-16
NO996107D0 (no) 1999-12-10
AP9801254A0 (en) 1998-06-30
UA70298C2 (uk) 2004-10-15
CA2293397C (en) 2004-08-31
HUP0004076A3 (en) 2003-05-28
BG64357B1 (bg) 2004-11-30
MY133027A (en) 2007-10-31
DZ2515A1 (fr) 2003-02-01
IL132808A (en) 2004-08-31
ES2251081T3 (es) 2006-04-16
NO996107L (no) 2000-02-10
CO4950584A1 (es) 2000-09-01
KR20010013633A (ko) 2001-02-26
PA8452001A1 (es) 2000-05-24
AU745006C (en) 2006-02-23
CN1145636C (zh) 2004-04-14
HN1998000074A (es) 1999-01-08
HUP0004076A2 (hu) 2001-04-28
NZ500652A (en) 2001-10-26
PL337497A1 (en) 2000-08-28
AP1189A (en) 2003-07-16
PE79999A1 (es) 1999-08-25
JP2000514097A (ja) 2000-10-24
TNSN98084A1 (fr) 2005-03-15
AU745006B2 (en) 2002-03-07
OA11226A (en) 2003-07-16
EA199901014A1 (ru) 2000-06-26
UY25041A1 (es) 2000-09-29
DE69832486T2 (de) 2006-07-27
ATE310742T1 (de) 2005-12-15
CA2293397A1 (en) 1998-12-17
NO315560B1 (no) 2003-09-22
BG103969A (en) 2000-07-31
GT199800075A (es) 1999-11-30
TW200418871A (en) 2004-10-01
DE69832486D1 (de) 2005-12-29
CN1259955A (zh) 2000-07-12
YU62999A (sh) 2002-10-18
JP3262806B2 (ja) 2002-03-04
SK168299A3 (en) 2000-09-12
IS1979B (is) 2005-01-14
IL132808A0 (en) 2001-03-19
MA24563A1 (fr) 1998-12-31
BR9810097A (pt) 2000-08-08
UA70298A (uk) 2004-10-15
TWI224106B (en) 2004-11-21
HRP980315A2 (en) 1999-04-30
AU7228198A (en) 1998-12-30
ZA985016B (en) 1999-12-10
EP0988309B1 (de) 2005-11-23

Similar Documents

Publication Publication Date Title
ID24530A (id) Turunan-turunan makrolidan yang tersubstitusi c-4
ID28110A (id) Surfaktan alkilbenzenasulfonat yang disempurnakan
EE200000291A (et) 2-fenüülasendatud imidasotriasinoonid
ID17140A (id) Ritsleting yang dicetak
ID27884A (id) Asam-asam indolealkanoat yang disubstitusikan.
ID20976A (id) Popok sekali pakai
ID21018A (id) Popok sekali pakai
ID26308A (id) Dihidropirimidin baru yang tersubstitusi secara 2-heterosiklik
ID20043A (id) Popok sekali pakai
DE69813014D1 (de) Verbesserte kleinmassige waferhaleeinrichtung
ID21602A (id) Popok sekali pakai
ID20975A (id) Popok sekali pakai
ID26334A (id) Morfolinol yang aktif secara farmasi
DE69831821D1 (de) Hochleitungs-zweischichtigesreibungsmaterial
ATE250583T1 (de) Substituierte 3-cyanochinoline
ID21197A (id) Popok sekali pakai
DE59905479D1 (de) FeRAM-ANORDNUNG
FR2771009B1 (fr) Biostimulant
ID16298A (id) Turunan-turunan 1,2,3,4-tetrahidronaftalena yang disubstitusi
DE59813670D1 (de) Bohrhammer
ID21770A (id) Plester yang mengandung felbinak
PT1203813E (pt) Pestivirus atenuados
NO20010154L (no) Brønnhulls-strekksvivelovergang
MA24648A1 (fr) Electrolyseur
ID23696A (id) Turunan siklobutilamina tersubstitusi